Hypertrophic cardiomyopathy

Citations 31-40 of 136 total displayed.

Editorials
Relevance of platelet activation in obstructive hypertrophic cardiomyopathy

Perry Elliott
Heart 2008; 94: 688-689. [Extract] [Full text] [PDF] [Request Permissions]  

Education in Heart
The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy

Tjeerd Germans and Albert C van Rossum
Heart 2008; 94: 510-518. [Extract] [Full text] [PDF] [Request Permissions] BMJ Learning: Take this module on BMJ Learning  

Original research
Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

D A Hughes, P M Elliott, J Shah, J Zuckerman, G Coghlan, J Brookes, and A B Mehta
Heart 2008 94: 153 -158; published online before print as 10.1136/hrt.2006.104026 [Abstract] [Full text] [PDF] [Request Permissions] [ web only appendix ]  

Original research
Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography

Osama I I Soliman, Paul Knaapen, Marcel L Geleijnse, Pieter A Dijkmans, Ashraf M Anwar, Attila Nemes, Michelle Michels, Wim B Vletter, Adriaan A Lammertsma, and Folkert J ten Cate
Heart 2007 93: 1204 -1212; published online before print as 10.1136/hrt.2006.110460 [Abstract] [Full text] [PDF] [Request Permissions]  

Education in Heart
Tako-tsubo cardiomyopathy (apical ballooning)

Holger M Nef, Helge Möllmann, and Albrecht Elsässer
Heart 2007; 93: 1309-1315. [Extract] [Full text] [PDF] [Request Permissions] [ web only references ] BMJ Learning: Take this module on BMJ Learning  

Original research
Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy

Anna Woo, Daniel Monakier, Louise Harris, Ann Hill, Prasad Shah, E Douglas Wigle, Harry Rakowski, Evelyn Rozenblyum, and Douglas A Cameron
Heart 2007; 93: 1044-1045. [Abstract] [Full text] [PDF] [Request Permissions]  

Education in Heart
Screening athletes for heart disease

Michael H Crawford
Heart 2007; 93: 875-879. [Extract] [Full text] [PDF] [Request Permissions] BMJ Learning: Take this module on BMJ Learning  

Original research
Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy

P Melacini, B J Maron, F Bobbo, C Basso, B Tokajuk, M Zucchetto, G Thiene, and S Iliceto
Heart 2007; 93: 708-710. [Abstract] [Full text] [PDF] [Request Permissions]  

Original research
Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study

Ali Nasermoaddeli, Katsuyuki Miura, Akira Matsumori, Yoshiyuki Soyama, Yuko Morikawa, Akira Kitabatake, Yutaka Inaba, and Hideaki Nakagawa
Heart 2007 93: 711 -715; published online before print as 10.1136/hrt.2006.095232 [Abstract] [Full text] [PDF] [Request Permissions]  

Education in Heart
The heart in Anderson-Fabry disease and other lysosomal storage disorders

Ales Linhart and Perry M Elliott
Heart 2007; 93: 528-535. [Extract] [Full text] [PDF] [Request Permissions] [ web only references ] BMJ Learning: Take this module on BMJ Learning